Roche R&D Spending Surge Reflects In-House Innovation, M&A Prices
‘Costs Being Squeezed Everywhere’ To Fund R&D
A surprise surge in Roche's R&D spending this year reflects high quality in-house innovation opportunities as well as high prices for external M&A targets, management said.
